Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Demand for Non-Invasive Dermatology Techniques and Ageing Population
4.2.2 Increasing R&D Investments for New Hyaluronic Acid Based Dermal Fillers
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 High Cost of Dermal Filling Procedures
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Single Phase
5.1.2 Duplex
5.2 By Application
5.2.1 Wrinkle Correction
5.2.2 Scar Treatment
5.2.3 Restoration of Volume
5.2.4 Lip Augmentation
5.2.5 Others
5.3 By End-User
5.3.1 Hospitals
5.3.2 Specialty Dermatology Clinics
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Allergan
6.1.2 Galderma S.A.
6.1.3 LG Chem Ltd.
6.1.4 MERZ PHARMACEUTICALS
6.1.5 Sinclair Pharma
6.1.6 Anika Therapeutics, Inc.
6.1.7 Teoxane S.A.
6.1.8 BioPlus Co., Ltd.
6.1.9 SCULPT Luxury Dermal Fillers LTD
6.1.10 Suneva Medical Inc.


7 MARKET OPPORTUNITIES AND FUTURE TRENDS